- Home
- GIGM vs CARA Comparison
GIGM vs CARA Comparison
Compare GIGM & CARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIGM
- CARA
- Stock Information
- Founded
- GIGM 1998
- CARA 2004
- Country
- GIGM Taiwan
- CARA United States
- Employees
- GIGM N/A
- CARA N/A
- Industry
- GIGM Computer Software: Programming Data Processing
- CARA Biotechnology: Pharmaceutical Preparations
- Sector
- GIGM Technology
- CARA Health Care
- Exchange
- GIGM Nasdaq
- CARA Nasdaq
- Market Cap
- GIGM 16.0M
- CARA 16.7M
- IPO Year
- GIGM 2000
- CARA 2014
- Fundamental
- Price
- GIGM $1.46
- CARA $0.25
- Analyst Decision
- GIGM
- CARA Hold
- Analyst Count
- GIGM 0
- CARA 3
- Target Price
- GIGM N/A
- CARA $1.00
- AVG Volume (30 Days)
- GIGM 9.7K
- CARA 1.6M
- Earning Date
- GIGM 10-30-2024
- CARA 11-14-2024
- Dividend Yield
- GIGM N/A
- CARA N/A
- EPS Growth
- GIGM N/A
- CARA N/A
- EPS
- GIGM N/A
- CARA N/A
- Revenue
- GIGM $3,085,000.00
- CARA $8,686,000.00
- Revenue This Year
- GIGM N/A
- CARA N/A
- Revenue Next Year
- GIGM N/A
- CARA N/A
- P/E Ratio
- GIGM N/A
- CARA N/A
- Revenue Growth
- GIGM N/A
- CARA N/A
- 52 Week Low
- GIGM $1.23
- CARA $0.23
- 52 Week High
- GIGM $1.53
- CARA $1.15
- Technical
- Relative Strength Index (RSI)
- GIGM 47.71
- CARA 41.07
- Support Level
- GIGM $1.39
- CARA $0.24
- Resistance Level
- GIGM $1.50
- CARA $0.30
- Average True Range (ATR)
- GIGM 0.03
- CARA 0.02
- MACD
- GIGM -0.01
- CARA -0.00
- Stochastic Oscillator
- GIGM 7.14
- CARA 40.45
About GIGM GigaMedia Limited
GigaMedia Ltd is a publisher of online games. It has only one reportable segment, Digital Entertainment service. Digital Entertainment service business operates a portfolio of online games, mainly targeting online game players across Europe, and Asia, including Greater China and Southeast Asia. The company's portfolio of online games includes predominantly PC-based, non-cash gambling, or casino casual games, including MahJong and various card and table games. The company's product lines include MahJong, AkaSeka, Yume 100, Fun Vegas, and others. The company operates in Taiwan and Hong Kong.
About CARA Cara Therapeutics Inc.
Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.